相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis:: Impact of protein binding?
Brian S. Schwartz et al.
ANNALS OF PHARMACOTHERAPY (2008)
Mechanisms of resistance to daptomycin in Enterococcus faecium
Clemente I. Montero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Effect of polysorbate 80 on oritavancin binding to plastic surfaces: Implications for susceptibility testing
Francis F. Arhin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL
David A. Boyd et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States
Rodrigo E. Mendes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Dalbavancin: A novel once-weekly lipoglycopeptide antibiotic
Marianne Billeter et al.
CLINICAL INFECTIOUS DISEASES (2008)
Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline
Kara B. Anthony et al.
CLINICAL INFECTIOUS DISEASES (2008)
Vancomycin-resistant Staphylococcus aureus: A perfect but geographically limited storm?
Fred C. Tenover
CLINICAL INFECTIOUS DISEASES (2008)
Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci
Marci Drees et al.
CLINICAL INFECTIOUS DISEASES (2008)
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms
Martin E. Stryjewski et al.
CLINICAL INFECTIOUS DISEASES (2008)
Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen
Janetta Top et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2008)
Oritavancin: a potential weapon in the battle against serious Gram-positive pathogens
Jared Crandon et al.
FUTURE MICROBIOLOGY (2008)
Outbreak of Enterococcus gallinarum infections after total knee arthroplasty
Michael P. Cooper et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE
Chamion N. Olivier et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
In vitro activity of telavancin against recent Gram-positive clinical isolates:: results of the 2004-05 Prospective European Surveillance Initiative
Deborah C. Draghi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient
Guido Werner et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Daptomycin resistance in Enterococcus faecalis prosthetic valve endocarditis
Alicia I. Hidron et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase
Cesar A. Arias et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin
C. van Nieuwkoop et al.
JOURNAL OF INFECTION (2008)
Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2008)
Telavancin: An antimicrobial with a multifunctional mechanism of action for the treatment of serious gram-positive infections
Steven N. Leonard et al.
PHARMACOTHERAPY (2008)
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan
Wenming Zhu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii
Laurence Damier-Piolle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding
Tiffanny Jones et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus
Jason M. Pogue et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Optimizing therapy for vancomycin-resistant enterococci (VRE)
Peter K. Linden
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women
Kalpana Gupta et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe
W. T. A. Jansen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model
Cesar A. Arias et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Rapid development of Acinetobacter baumannii resistance to tigecycline
Gail E. Reid et al.
PHARMACOTHERAPY (2007)
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes
Shazad Mushtaq et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Antibiotic efflux pumps in Gram-negative bacteria:: the inhibitor response strategy
Abdallah Mahamoud et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including β-lactamase-producing and vancomycin-resistant isolates
Cesar A. Arias et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program
Lalitagauri M. Deshpande et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo
Nadege Bourgeois-Nicolaos et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria
Karen L. Leach et al.
MOLECULAR CELL (2007)
Vancomycin-resistant Enterococcus faecalis endocarditis:: Linezolid failure and strain characterization of virulence factors
Constantine Tsigrelis et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Daptomycin-resistant Enteroccoccus faecium in a patient with no prior exposure to daptomycin
M. H. Fraher et al.
JOURNAL OF HOSPITAL INFECTION (2007)
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Anton Y. Peleg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid
Seok-Ming Toh et al.
MOLECULAR MICROBIOLOGY (2007)
Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: A case report
Zeina A. Kanafani et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species
C. Andrew DeRyke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Tigecycline: A critical analysis
Gary E. Stein et al.
CLINICAL INFECTIOUS DISEASES (2006)
Emergence of Enterococcus faecalis susceptible to quinupristin/dalfopristin in Greece
E. Petinaki et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptograrnin A antibiotics
Katherine S. Long et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid
DW Wareham et al.
JOURNAL OF INFECTION (2006)
Dihydrofolate reductase inhibitors as antibacterial agents
S Hawser et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage
MG Bonora et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
De novo daptomycin nonsusceptibility in a clinical isolate
EP Lesho et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center
Thomas E. Dobbs et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens
JM Streit et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin
G Pankey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections
LE Jauregui et al.
CLINICAL INFECTIOUS DISEASES (2005)
Endocarditis due to vancomycin-resistant enterococci: Case report and review of the literature
MP Stevens et al.
CLINICAL INFECTIOUS DISEASES (2005)
Tigecycline is modified by the flavin-dependent monooxygenase TetX
IF Moore et al.
BIOCHEMISTRY (2005)
The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: Results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam
EJ Ellis-Grosse et al.
CLINICAL INFECTIOUS DISEASES (2005)
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: Analysis of pooled clinical trial data
T Babinchak et al.
CLINICAL INFECTIOUS DISEASES (2005)
Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia
JK Long et al.
MAYO CLINIC PROCEEDINGS (2005)
Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection
LS Munoz-Price et al.
CLINICAL INFECTIOUS DISEASES (2005)
Molecular characterization of a widespread, pathogenic, and antibiotic resistance-receptive Enterococcus faecalis lineage and dissemination of its putative pathogenicity island
SR Nallapareddy et al.
JOURNAL OF BACTERIOLOGY (2005)
A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503
C Kehrenberg et al.
MOLECULAR MICROBIOLOGY (2005)
Infective endocarditis - Diagnosis, antimicrobial therapy, and management of complications - A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association
LM Baddour et al.
CIRCULATION (2005)
Mixed-lipid storage disorder induced in macrophages and fibroblasts by oritavancin (LY333328), a new glycopeptide antibiotic with exceptional cellular accumulation
F Van Bambeke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy
K Sabol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus
DL Higgins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection
CA DiazGranados et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres
AC Gales et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Differences in the Enterococcus faecalis lsa locus that influence susceptibility to quinupristin-dalfopristin and clindamycin
KV Singh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose
GJ Fetterly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteria
A King et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid:: a comparison with quinupristin-dalfopristin
II Raad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Enterococcus faecalis resistant to linezolid:: Case series and review of the literature
BS Burleson et al.
PHARMACOTHERAPY (2004)
Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin:: Efficacy of the ex vivo synergism method
C Tascini et al.
JOURNAL OF CHEMOTHERAPY (2004)
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
D Cardo et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2004)
Quinupristin-dalfopristin resistance in gram-positive bacteria: Mechanism of resistance and epidemiology
E Hershberger et al.
CLINICAL INFECTIOUS DISEASES (2004)
Effects of efflux transporter genes on susceptibility of Escheichia coli to tigecycline (GAR-936)
T Hirata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Isolated pulmonic valve infective endocarditis: A persistent challenge
N Hamza et al.
INFECTION (2004)
Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin
Joerg M. Harms et al.
BMC BIOLOGY (2004)
Pharmacokinetics, safety, and tolerability of ascending single intravenous doses of oritavancin administered to healthy human subjects
SM Bhavnani et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2004)
Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid
JY Ang et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Ribosomal protection proteins and their mechanism of tetracycline resistance
SR Connell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus
LM Weigel et al.
SCIENCE (2003)
The vanG glycopeptide resistance operon from Enterococcus faecalis revisited
F Depardieu et al.
MOLECULAR MICROBIOLOGY (2003)
Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis
M Lobritz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Outcomes associated with vancomycin-resistant enterococci: A meta-analysis
CD Salgado et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model
PK Dandekar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Failure of linezolid treatment for enterococcal endocarditis
SM Zimmer et al.
CLINICAL INFECTIOUS DISEASES (2003)
Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient:: Cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin
RL Thompson et al.
SOUTHERN MEDICAL JOURNAL (2003)
Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus
JA Silverman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Nonsense mutations in the lsa-like gene in Enterococcus faecalis isolates susceptible to lincosamides and streptogramins A
J Dina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid
S Rahim et al.
CLINICAL INFECTIOUS DISEASES (2003)
Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000-2001
IA Critchley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene
S Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Activity of tigecycline (GAR-936), a novel glycylcycline, against enterococci in the mouse peritonitis model
EC Nannini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Linezolid for the treatment of multidrug-resistant, gram-positive infections: Experience from a compassionate-use program
MC Birmingham et al.
CLINICAL INFECTIOUS DISEASES (2003)
Activity and diffusion of tigecycline (GAR-936) in experimental enterococcal endocarditis
AS Lefort et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria
P Schneider et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Mechanism of action of oritavancin and related glycopeptide antibiotics
NE Allen et al.
FEMS MICROBIOLOGY REVIEWS (2003)
Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: Evidence for a gene dosage effect on linezolid MICs
KA Ruggero et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2003)
Antimicrobial susceptibility of vancomycin-resistant enterococcus faecium: Potential utility of fosfomycin
NK Shrestha et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2003)
Successful treatment of Enterococcus faecalis prosthetic valve endocarditis with linezolid
N Rao et al.
CLINICAL INFECTIOUS DISEASES (2002)
Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis
SH Marshall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori
MM Gerrits et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Hexapeptide derivatives of glycopeptide antibiotics: Tools for mechanism of action studies
NE Allen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin
KV Singh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Prosthetic valve endocarditis due to vancomycin-resistant Enterococcus faecium:: Treatment with chloramphenicol plus minocycline
A Safdar et al.
CLINICAL INFECTIOUS DISEASES (2002)
Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline
CA Trieber et al.
JOURNAL OF BACTERIOLOGY (2002)
In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin
MB Perri et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2002)
Nosocomial spread of linezolid-resistant, vancomycin-resistant enterococcus faecium
IA Herrero et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin
PK Linden et al.
CLINICAL INFECTIOUS DISEASES (2001)
Linezolid resistance in a clinical isolate of Staphylococcus aureus
S Tsiodras et al.
LANCET (2001)
Resistance to linezolid: Characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci
J Prystowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance
I Chopra et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2001)
Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid
HM Babcock et al.
CLINICAL INFECTIOUS DISEASES (2001)
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
RD Gonzales et al.
LANCET (2001)
Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals
RJL Willems et al.
LANCET (2001)
Identification of vat(E-3), a novel gene encoding resistance to quinupristin-dalfopristin in a strain of Enterococcus faecium from a hospital patient in the United Kingdom
H Soltani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations
RL Akins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia
JC Ricaurte et al.
CLINICAL MICROBIOLOGY AND INFECTION (2001)
Recent advances in the formation of the bacterial peptidoglycan monomer unit
J van Heijenoort
NATURAL PRODUCT REPORTS (2001)
Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.
CJ Donskey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Therapeutic efficacy of GAR-936, a novel glycylcycline, in a rat model of experimental endocarditis
TM Murphy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis
A Lefort et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Development of daptomycin for Gram-positive infections
FP Tally et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Aminoglycoside resistance in enterococci
JW Chow
CLINICAL INFECTIOUS DISEASES (2000)
Novel mechanism of β-lactam resistance due to bypass of DD-transpeptidation in Enterococcus faecium
JL Mainardi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174
CA Arias et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Drug therapy: Vancomycin-resistant enterococcal infections.
BE Murray
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract
CJ Donskey et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Identification of a plasmid-borne chloramphenicol-florfenicol resistance gene in Staphylococcus sciuri
S Schwarz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance
V Kak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections
JW Chien et al.
CLINICAL INFECTIOUS DISEASES (2000)
Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent
SJ Projan
PHARMACOTHERAPY (2000)
分享论文
